Literature DB >> 8398269

Second primary neoplasms following breast cancer in Saarland, Germany, 1968-1987.

H Brenner1, S Siegle, C Stegmaier, H Ziegler.   

Abstract

A statewide cohort study on the occurrence of second primary neoplasms was conducted among 9678 women first diagnosed with breast cancer in Saarland, Germany between 1968 and 1987. A total number of 409 second primary neoplasms was observed compared to 328 cases that would have been expected based on the incidence rates of the general population (standardised incidence ratio, SIR = 1.25). This elevation in incidence of second neoplasms was primarily due to increased occurrence of cancer of the opposite breast (SIR = 2.48), which was most pronounced for patients below the age of 50 (SIR = 4.20) and within the first 5 years after diagnosis (SIR = 2.91). There was a moderate elevation in incidence of malignant tumours of the ovaries (SIR = 1.46), while the incidence of most other malignancies was lower than in the general population. Our results, which are in agreement with previous findings from Northern Europe, the U.S.A. and Japan provide valuable background information for aetiological research, as well as for surveillance of breast cancer patients.

Entities:  

Mesh:

Year:  1993        PMID: 8398269     DOI: 10.1016/0959-8049(93)90013-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  8 in total

Review 1.  Skin cancer risk in BRCA1/2 mutation carriers.

Authors:  P V Gumaste; L A Penn; R M Cymerman; T Kirchhoff; D Polsky; B McLellan
Journal:  Br J Dermatol       Date:  2015-04-29       Impact factor: 9.302

2.  A descriptive study of second primary malignancies associated to breast cancer in a mexican Hispanic population.

Authors:  S Vidal-Millan; I Zeichner-Gancz; D Flores-Estrada; B E Vela-Rodríguez; M I Vazquez-López; C D Robles-Vidal; M T Ramirez-Ugalde; M Chávez-MacGregor
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

3.  Second primary cancers following breast cancer in the Japanese female population.

Authors:  H Tanaka; H Tsukuma; H Koyama; Y Kinoshita; N Kinoshita; A Oshima
Journal:  Jpn J Cancer Res       Date:  2001-01

4.  Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer.

Authors:  Daniele Giardiello; Iris Kramer; Maartje J Hooning; Michael Hauptmann; Esther H Lips; Elinor Sawyer; Alastair M Thompson; Linda de Munck; Sabine Siesling; Jelle Wesseling; Ewout W Steyerberg; Marjanka K Schmidt
Journal:  NPJ Breast Cancer       Date:  2020-11-03

5.  Relation of risk of contralateral breast cancer to the interval since the first primary tumour.

Authors:  C Rubino; R Arriagada; S Delaloge; M G Lê
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640

6.  Second malignancies after breast cancer: the impact of different treatment modalities.

Authors:  Y M Kirova; Y De Rycke; L Gambotti; J-Y Pierga; B Asselain; A Fourquet
Journal:  Br J Cancer       Date:  2008-02-12       Impact factor: 7.640

7.  Epidemiologic and molecular risk factors for contralateral breast cancer among young women.

Authors:  C I Li; K E Malone; P L Porter; J R Daling
Journal:  Br J Cancer       Date:  2003-08-04       Impact factor: 7.640

8.  The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands.

Authors:  Michael Schaapveld; Otto Visser; W J Louwman; Pax H B Willemse; Elisabeth G E de Vries; Winette T A van der Graaf; Renée Otter; Jan Willem W Coebergh; Flora E van Leeuwen
Journal:  Breast Cancer Res Treat       Date:  2007-08-09       Impact factor: 4.872

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.